Refine
Year of publication
- 2017 (19) (remove)
Document Type
- Article (11)
- ZIB-Report (8)
Language
- English (19)
Is part of the Bibliography
- no (19)
Keywords
- Mathematical modeling (2)
- Real-time cell analyzer (2)
- Toxicity (2)
- metastability (2)
- reaction coordinate (2)
- transfer operator (2)
- transition manifold (2)
- Donsker-Varadhan principle (1)
- Galerkin method (1)
- IC_{50} (1)
Institute
The article surveys and extends variational formulations of the thermodynamic free
energy and discusses their information-theoretic content from the perspective of mathematical statistics. We revisit the well-known Jarzynski equality for nonequilibrium free energy sampling within the framework of importance sampling and Girsanov change-of-measure transformations. The implications of the different variational formulations for designing efficient stochastic optimization and nonequilibrium simulation algorithms for computing free energies are discussed and illustrated.
We consider complex dynamical systems showing metastable behavior but no local
separation of fast and slow time scales. The article raises the question of whether
such systems exhibit a low-dimensional manifold supporting its effective dynamics.
For answering this question, we aim at finding nonlinear coordinates, called reaction
coordinates, such that the projection of the dynamics onto these coordinates preserves
the dominant time scales of the dynamics. We show that, based on a specific
reducibility property, the existence of good low-dimensional reaction coordinates
preserving the dominant time scales is guaranteed. Based on this theoretical framework,
we develop and test a novel numerical approach for computing good reaction
coordinates. The proposed algorithmic approach is fully local and thus not prone to
the curse of dimension with respect to the state space of the dynamics. Hence, it is
a promising method for data-based model reduction of complex dynamical systems
such as molecular dynamics.
Motivation: High-throughput proteomics techniques, such as mass spectrometry
(MS)-based approaches, produce very high-dimensional data-sets. In a clinical
setting one is often interested how MS spectra dier between patients of different
classes, for example spectra from healthy patients vs. spectra from patients
having a particular disease. Machine learning algorithms are needed to (a)
identify these discriminating features and (b) classify unknown spectra based on
this feature set. Since the acquired data is usually noisy, the algorithms should be
robust to noise and outliers, and the identied feature set should be as small as
possible.
Results: We present a new algorithm, Sparse Proteomics Analysis (SPA), based
on the theory of Compressed Sensing that allows to identify a minimal
discriminating set of features from mass spectrometry data-sets. We show how
our method performs on artificial and real-world data-sets.
Background: High-throughput proteomics techniques, such as mass spectrometry (MS)-based approaches, produce very high-dimensional data-sets. In a clinical setting one is often interested in how mass spectra differ between patients of different classes, for example spectra from healthy patients vs. spectra from patients having a particular disease. Machine learning algorithms are needed to (a) identify these discriminating features and (b) classify unknown spectra based on this feature set. Since the acquired data is usually noisy, the algorithms should be robust against noise and outliers, while the identified feature set should be as small as possible.
Results: We present a new algorithm, Sparse Proteomics Analysis (SPA),based on thet heory of compressed sensing that allows us to identify a minimal discriminating set of features from mass spectrometry data-sets. We show (1) how our method performs on artificial and real-world data-sets, (2) that its performance is competitive with standard (and widely used) algorithms for analyzing proteomics data, and (3) that it is robust against random and systematic noise. We further demonstrate the applicability of our algorithm to two previously published clinical data-sets.
Molecular dynamics (MD) simulations face challenging problems since
the timescales of interest often are much longer than what is possible
to simulate and even if sufficiently long simulation are possible the complex
nature of the resulting simulation data makes interpretation difficult.
Markov State Models (MSMs) help to overcome these problems by making
experimentally relevant timescales accessible via coarse grained representations
that also allows for convenient interpretation. However, standard
set-based MSMs exhibit some caveats limiting their approximation quality
and statistical significance. One of the main caveats results from the fact
that typical MD trajectories repeatedly re-cross the boundary between
the sets used to build the MSM which causes statistical bias in estimating
the transition probabilities between these sets. In this article, we present
a set-free approach to MSM building utilizing smooth overlapping ansatz
functions instead of sets and an adaptive refinement approach. This kind
of meshless discretization helps to overcome the recrossing problem and
yields an adaptive refinement procedure that allows to improve the quality
of the model while exploring state space and inserting new ansatz
functions into the MSM.
Before the onset of sprouting angiogenesis, the endothelium is prepatterned for the positioning of tip and stalk cells. Both cell identities are not static, as endothelial cells (ECs) constantly compete for the tip cell position in a dynamic fashion. Here, we show that both bone morphogenetic protein (BMP) 2 and BMP6 are proangiogenic in vitro and ex vivo and that the BMP type I receptors, activin receptor-like kinase (ALK)3 and ALK2, play crucial and distinct roles in this process. BMP2 activates the expression of tip cell–associated genes, such as DLL4 (delta-like ligand 4) and KDR (kinase insert domain receptor), and p38-heat shock protein 27 (HSP27)–dependent cell migration, thereby generating tip cell competence. Whereas BMP6 also triggers collective cell migration via the p38-HSP27 signaling axis, BMP6 induces in addition SMAD1/5 signaling, thereby promoting the expression of stalk cell–associated genes, such as HES1 (hairy and enhancer of split 1) and FLT1 (fms-like tyrosine kinase 1). Specifically, ALK3 is required for sprouting from HUVEC spheroids, whereas ALK2 represses sprout formation. We demonstrate that expression levels and respective complex formation of BMP type I receptors in ECs determine stalk vs. tip cell identity, thus contributing to endothelial plasticity during sprouting angiogenesis. As antiangiogenic monotherapies that target the VEGF or ALK1 pathways have not fulfilled efficacy objectives in clinical trials, the selective targeting of the ALK2/3 pathways may be an attractive new approach.